MS-SMART

Multiple sclerosis - secondary progressive multi-arm randomisation trial.

Title	MS-SMART
Description	Multiple sclerosis - secondary progressive multi-arm randomisation trial A multi-arm phase IIb randomised, double blind placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
Status	Complete
PI	Prof Siddharthan Chandran
Edinburgh Imaging Collaborator	Prof Ian Marshall Dr Scott Semple
Disease	Multiple Sclerosis (MS)
Facility / resource	EIF QMRI
Project type	Multi-centre randomised placebo-control study
Funding	Medical Research Council (MRC) MS society National Institute for Health Research (NIHR) National Institute for Health Research University College London Hospitals Biomedical Research Centre Sanofi University College London University of Edinburgh

This article was published on 22 Jul, 2019